JP Morgan Chase’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,508
Closed -$142K 7434
2023
Q4
$142K Sell
3,508
-5,629
-62% -$215K ﹤0.01% 5571
2023
Q3
$358K Buy
+9,137
New +$364K ﹤0.01% 4682
2023
Q2
Sell
-2,744
Closed -$115K 6928
2023
Q1
$115K Buy
+2,744
New +$115K ﹤0.01% 5361
2015
Q3
Sell
-17,558
Closed -$751K 3920
2015
Q2
$751K Buy
+17,558
New +$754K ﹤0.01% 3411
2014
Q4
Sell
-19,259
Closed -$739K 4224
2014
Q3
$739K Buy
+19,259
New +$709K ﹤0.01% 3499

Other funds holding BME

JP Morgan Chase's BME Position: Q1 2024 in Review

JP Morgan Chase sold out of BlackRock Health Sciences Trust (BME) in Q1 2024, closing a stake of 3,508 shares — an estimated $142K sold.

JP Morgan Chase first reported a position in BME in Q3 2014 and held it in 5 quarters. The position peaked at $751K in Q2 2015. 74 funds tracked by Wall St. Rank hold BME as of Q1 2024.

  • JP Morgan Chase reported no remaining BlackRock Health Sciences Trust position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 3,508 BlackRock Health Sciences Trust shares in Q1 2024, an estimated $142K.
  • JP Morgan Chase first reported a position in BlackRock Health Sciences Trust in Q3 2014 and held it in 5 quarters.
  • JP Morgan Chase's BlackRock Health Sciences Trust position peaked at $751K in Q2 2015.
  • 74 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.